Physician profile
Gretchen Key
NPI 1366203879
$1,688.24
in general payments reported to CMS, 2019-2025
11 companies · $1,087 in 2025
The $1,087 reported for 2025 was more than what 82% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $601 · 2025: $1,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,577 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,576.75 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $560.30 | 2024-2025 | Invega Sustenna, Invega Trinza |
| Neurocrine Biosciences, INC. | $348.27 | 2024-2025 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $257.53 | 2024-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $204.57 | 2024-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Teva Pharmaceuticals USA, INC. | $159.22 | 2024-2025 | Uzedy |
| Alkermes, INC. | $50.06 | 2024-2025 | Aristada, Lybalvi |
| Abbvie INC. | $26.11 | 2025 | |
| Ironshore Pharmaceuticals INC. | $24.27 | 2024 | |
| Collegium Pharmaceutical, INC. | $24.19 | 2025 | Jornay Pm |
| Lundbeck LLC | $20.59 | 2025 | Rexulti |
| Noven Therapeutics, LLC | $13.13 | 2024 | Xelstrym, Secuado |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gretchen Key listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.